Combined therapy for treating solid tumors with chemotherapy and angiogenic inhibitors

DOI10.3934/DCDSB.2020343MaRDI QIDQ2033852zbMATH OpenOpenAlexFDO

Authors Antonio Mastroberardino, Adam E. Glick

Publication date 18 June 2021

Published in Discrete and Continuous Dynamical Systems. Series B (Search for Journal in Brave)

Full work available at URL https://doi.org/10.3934/dcdsb.2020343

zbMATH Keywords

anti-angiogenic treatmentmathematical oncologytumor microenvironment

Mathematics Subject Classification ID

Stability of solutions to ordinary differential equations (34D20) Medical applications (general) (92C50)

Recommendations

• A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy
• Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
• On dynamic tumor eradication conditions under combined chemical/anti-angiogenic therapies
• A cancer treatment based on synergy between anti-angiogenic and immune cell therapies
• Mathematical modelling of chemotherapy combined with bevacizumab

Cites work

• A cancer model for the angiogenic switch
• A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy
• A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
• A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology
• A validated mathematical model of tumor growth including tumor-host interaction, cell-mediated immune response and chemotherapy
• An optimal control approach for the treatment of solid tumors with angiogenesis inhibitors
• AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
• Automatic Selection of Methods for Solving Stiff and Nonstiff Systems of Ordinary Differential Equations
• Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy
• Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
• Modeling immunotherapy of the tumor -- immune interaction
• Modelling lymphoma therapy and outcome
• Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
• On optimal delivery of combination therapy for tumors
• Optimal and suboptimal protocols for a mathematical model for tumor anti-angiogenesis in combination with chemotherapy
• Optimal bang-bang controls for a two-compartment model in cancer chemotherapy
• Optimal Control Applied to Competing Chemotherapeutic Cell-Kill Strategies
• Optimal control for mathematical models of cancer therapies. An application of geometric methods
• Optimal scheduling of radiotherapy and angiogenic inhibitors
• Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999)

Cited in

(8)

• Sensitivity of combined chemo- and antiangiogenic therapy results in different models describing cancer growth
• Tumor development under combination treatments with anti-angiogenic therapies
• A cancer treatment based on synergy between anti-angiogenic and immune cell therapies
• Anti-angiogenic therapy based on the binding to receptors
• An optimization method for treating solid tumors with combined therapy using the great deluge algorithm
• A mathematical model to study low-dose metronomic scheduling for chemotherapy
• Ultimate dynamics of a cancer model with angiogenic switch and combined therapy
• A mathematical study of anti-VEGF and cytotoxic therapies of cancer with optimal control

This page was built for publication: Combined therapy for treating solid tumors with chemotherapy and angiogenic inhibitors

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2033852)